Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 PharmaBlock Acquires cGMP Mfg. Facility | Contract Pharma

What are you searching for?

Sign in
Breaking News

PharmaBlock Acquires cGMP Mfg. Facility

The 1,436,000ft2 (approximately 133,400m2) site was purchased from Porton Pharma Solutions Ltd

By: Betsy Louda

, Contract Pharma

PharmaBlock Sciences has acquired a GMP compliant manufacturing facility in China from Porton Pharma Solutions Ltd. 

The 1,436,000ft2 (approximately 133,400m2) site, located in a State-level chemical industry park in Shangyu, Zhejiang Province, has been operating as a multi-purpose GMP compliant facility since December 2015. Assets include reactors from 300L to 6300L, with more than 180m3 of combined reactor volume. The facility is well equipped to practice a wide range of chemistry synthesis and enabling technologies, and expands PharmaBlock’s manufacturing capacity of building blocks, RSMs, non-GMP and GMP intermediates. 

It has delivered 100+ products from Phase I to commercial, with production over 150 MT since January 2016. Phase II construction will be implemented this year to establish API manufacturing capabilities.

“PharmaBlock’s new Shangyu site is well positioned to respond to customers’ increasing demand for preclinical-, clinical- and commercial- stage manufacturing of intermediates. The acquisition of this site provides additional GMP capacity and is supplement to our existing assets in Shandong Dezhou site.” said Dr. Minmin Yang, chairman of PharmaBlock. “We will initiate the Phase II construction of Shangyu facility within this year to establish API manufacturing capabilities. In this way, PharmaBlock will soon be able to offer customers an integrated supply chain from building blocks, non-GMP intermediates, GMP intermediates to APIs.”

 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics